MARKET

ALXN

ALXN

Alexion Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

113.27
+0.76
+0.68%
After Hours: 113.27 0 0.00% 17:49 01/17 EST
OPEN
113.15
PREV CLOSE
112.51
HIGH
114.35
LOW
112.47
VOLUME
1.94M
TURNOVER
--
52 WEEK HIGH
141.86
52 WEEK LOW
94.59
MARKET CAP
25.07B
P/E (TTM)
18.77
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ALXN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ALXN News

  • Morgan Stanley Maintains Equal-Weight on Alexion Pharmaceuticals, Raises Price Target to $131
  • Benzinga.18h ago
  • Alexion to Report Fourth Quarter and Full Year 2019 Results on Thursday, January 30, 2020
  • Business Wire.19h ago
  • Alexion to Start Pivotal Study on Ultomiris for ALS in Q1
  • Zacks.2d ago
  • 3 Healthcare Stocks That Are Coming Back to Life
  • TipRanks.2d ago

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.07%

Hot Stocks

Name
Price
%Change

About ALXN

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.
More

Webull offers Alexion Pharmaceuticals, Inc. (ALXN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.